Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy ; volume:6 ; number:1 ; day:03 ; month:6 ; year:2008 ; pages:1-6 ; date:12.2008
Thrombosis journal ; 6, Heft 1 (03.6.2008), 1-6, 12.2008
- Creator
-
Srivastava, Ajay
Hudson, Michael
Hamoud, Ihab
Cavalcante, Joao
Pai, Chetan
Kaatz, Scott
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-9560-6-6
- URN
-
urn:nbn:de:101:1-2021080921440904429635
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Srivastava, Ajay
- Hudson, Michael
- Hamoud, Ihab
- Cavalcante, Joao
- Pai, Chetan
- Kaatz, Scott
- SpringerLink (Online service)
Other Objects (12)
Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin
The use of warfarin in veterans with atrial fibrillation
Grimmen - 1983 "Warfarin"
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
A test of financial incentives to improve warfarin adherence
Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin
The use of warfarin in veterans with atrial fibrillation
Grimmen - 1983 "Warfarin"
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
A test of financial incentives to improve warfarin adherence
Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin
The use of warfarin in veterans with atrial fibrillation
Grimmen - 1983 "Warfarin"
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation